The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prostate cancer brain metastasis in a contemporary cohort.
 
Paul Brittain
No Relationships to Disclose
 
Derek Smith
No Relationships to Disclose
 
Dexiang Gao
No Relationships to Disclose
 
Elizabeth Riley Kessler
Research Funding - Medivation/Astellas
 
Brandon David Bernard
No Relationships to Disclose
 
D. Ryan Ormond
No Relationships to Disclose
 
Elaine Tat Lam
No Relationships to Disclose
 
Brian D. Kavanagh
Research Funding - Janssen (Inst)
 
Thomas W. Flaig
Leadership - Aurora Oncology
Stock and Other Ownership Interests - Aurora Oncology
Honoraria - BN ImmunoTherapeutics; GTx
Consulting or Advisory Role - GTX
Research Funding - Agensys; Aragon Pharmaceuticals; Astellas Pharma; astrazeneca/MedImmune; Bavarian Nordic; Bristol-Myers Squibb; Cougar Biotechnology; Dendreon; Exelixis; GTx; Janssen Oncology; La Roche-Posay; Lilly; Medivation; Novartis; Pfizer; Roche/Genentech; Sanofi; Seagen; Sotio; Tokai Pharmaceuticals
Patents, Royalties, Other Intellectual Property - The University of Colorado has filed 2 patents related in which I am an inventor. These are related to early-stage bladder cancer treatment and detection. Neither is commercialized or licensed at this time.
Travel, Accommodations, Expenses - Bavarian Nordic; GTx